Search research articles
Contact Us
Filters
Showing results (81-90 of 280) with videos related to
Page
of 28
Sort By:
Antiviral Therapy
|
June 27, 2007
Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial
Henry Lik-Yuen Chan, Hao Wang, Junqi Niu, et al.
Journal of Gastroenterology and Hepatology
|
May 5, 2022
Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients
Xiaomei Wang, Xiuzhu Gao, Ruihong Wu, et al.
Antiviral Research
|
April 17, 2024
A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B
Jie Zhou, Yunhao Hua, Yuwei Liu, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 2008
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals
Yudong Liu, Hui Wang, Na Du, et al.
European Journal of Gastroenterology & Hepatology
|
May 12, 2016
Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients
Huan Wang, Hongqin Xu, Limei Qu, et al.
Scientific Reports
|
January 28, 2017
Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013
Jing Wu, Hongqin Xu, Xiuting He, et al.
Journal of Proteome Research
|
September 6, 2012
Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry
Lina Zhou, Lili Ding, Peiyuan Yin, et al.
Cancer Genetics
|
December 28, 2011
A novel t(8;13)(q21;q22) translocation in a pediatric lipoma
Jinglan Jin, Junqi Niu, Young-Mi Kim, et al.
Experimental and Therapeutic Medicine
|
June 8, 2017
Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment
Xu Li, Qinglong Jin, Hongqin Xu, et al.
Mediators of Inflammation
|
February 9, 2012
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C
Juan Wang, Pingwei Zhao, Hui Guo, et al.
Page
of 28
Search research articles
Search
Showing results (81-90 of 280) with videos related to
Sort By:
Page
of 28
Antiviral Therapy
|
June 27, 2007
Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial
Henry Lik-Yuen Chan, Hao Wang, Junqi Niu, et al.
Journal of Gastroenterology and Hepatology
|
May 5, 2022
Serum qAnti-HBc combined with ALT and HBsAg predicts significant hepatic inflammation in HBeAg-positive immune active patients
Xiaomei Wang, Xiuzhu Gao, Ruihong Wu, et al.
Antiviral Research
|
April 17, 2024
A mutual regulatory loop between transcription factor Yin Yang 1 and hepatitis B virus replication influences chronic hepatitis B
Jie Zhou, Yunhao Hua, Yuwei Liu, et al.
Antimicrobial Agents and Chemotherapy
|
November 26, 2008
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals
Yudong Liu, Hui Wang, Na Du, et al.
European Journal of Gastroenterology & Hepatology
|
May 12, 2016
Red blood cell distribution width and globulin, noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients
Huan Wang, Hongqin Xu, Limei Qu, et al.
Scientific Reports
|
January 28, 2017
Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013
Jing Wu, Hongqin Xu, Xiuting He, et al.
Journal of Proteome Research
|
September 6, 2012
Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry
Lina Zhou, Lili Ding, Peiyuan Yin, et al.
Cancer Genetics
|
December 28, 2011
A novel t(8;13)(q21;q22) translocation in a pediatric lipoma
Jinglan Jin, Junqi Niu, Young-Mi Kim, et al.
Experimental and Therapeutic Medicine
|
June 8, 2017
Chronic hepatitis B patients with high liver fibrosis levels should receive antiviral treatment
Xu Li, Qinglong Jin, Hongqin Xu, et al.
Mediators of Inflammation
|
February 9, 2012
Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C
Juan Wang, Pingwei Zhao, Hui Guo, et al.
Page
of 28